Company Filing History:
1 out of 3 
1 out of 12 Years Active: 2021
Title: Innovations of Tomas Pilzys in Medical Diagnostics
Introduction
Tomas Pilzys is a notable inventor based in Vilnius, Lithuania. He has made significant contributions to the field of medical diagnostics, particularly in the diagnosis of IgA nephropathy. His innovative approach utilizes urine proteins as markers, showcasing his expertise in biochemistry and medical research.
Latest Patents
Tomas Pilzys holds a patent titled "Methods for diagnosis, differentiation and monitoring using urine proteins as markers in IgA nephropathy." This patent describes a method for diagnosing IgA nephropathy by using a combination of alpha-1B-glycoprotein (A1BG), orosomucoid 1 (ORMI), and Ig lambda-2 chain C regions (IGLC2) as protein markers found in urine samples. This innovative method has the potential to improve diagnostic accuracy and patient outcomes.
Career Highlights
Throughout his career, Tomas Pilzys has worked with esteemed institutions such as the Institute of Biochemistry and Biophysics of the Polish Academy of Sciences and the Medical University of Warsaw. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Tomas has collaborated with notable colleagues, including Krzysztof Mucha and Leszek Paczek. These collaborations have further enriched his research and have led to advancements in the field of medical diagnostics.
Conclusion
Tomas Pilzys is a distinguished inventor whose work in medical diagnostics has the potential to transform the way IgA nephropathy is diagnosed and monitored. His innovative methods and collaborations highlight his commitment to advancing healthcare through scientific research.